Senior insider sale
Chief Financial Officer at CENTESSA PHARMACEUTICALS PLC — senior position signals high conviction
$2.60M
97.19K shares
What this filing means
WEINHOFF GREGORY M plans to sell 97.19K shares of CENTESSA PHARMACEUTICALS PLC valued at approximately $2.60M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/26/2026ACC: 0001969223-26-000400
Officer· Chief Financial Officer
Since May 2021
97.19K
Shares to sell
$2.60M
Approx. market value
24K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
3/26/2026
24KTotal acquired24K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/26/2026 | Exercise of Stock Options Cash | 24K | — |
| Total | 24K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
73.20K
Market value
$1.93M
3/13/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
24K
Market value
$675.5K
3/26/2026
Total
Units
97.19K
Value
$2.60M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/13/2026 | 73.20K | $1.93M | — | Completed |
| Planned — Approximate Date | ||||
3/26/2026 | 24K | $675.5K | NASDAQ | Planned |
| Total | 97.19K | $2.60M | ||